Beam Therapeutics
Trade Beam Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BEAM
Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201.
BEAM Key Statistics
Stock Snapshot
The current Beam Therapeutics(BEAM) stock price is $27.06, with a market capitalization of 2.76B. The stock trades at a price-to-earnings (P/E) ratio of -26.13.
On 2026-03-09, Beam Therapeutics(BEAM) stock traded between a low of $25.55 and a high of $27.48. Shares are currently priced at $27.06, which is +5.9% above the low and -1.5% below the high.
The Beam Therapeutics(BEAM)'s current trading volume is 537.62K, compared to an average daily volume of 2.37M.
In the last year, Beam Therapeutics(BEAM) shares hit a 52-week high of $36.44 and a 52-week low of $13.53.
In the last year, Beam Therapeutics(BEAM) shares hit a 52-week high of $36.44 and a 52-week low of $13.53.
Analyst ratings
89%
of 18 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.